The PMI of the manufacturing industry has increased from the previous month, and the pharmaceutical equipment industry will welcome the positive

[ Chemical Machinery Equipment Network Market Analysis ] Recently, a report showed that China's Manufacturing Purchasing Managers Index (PMI) was 51.
9% in March, an increase of 1.
3 percentage points from the previous month.
Based on this, in the first two months of this year, the total profit of the general equipment manufacturing industry has increased by 319.
3% year-on-year and 42.
89% year-on-year; *The total profit of the equipment manufacturing industry has increased by 399.
0% year-on-year, year-on-year compared to 2019 In terms of an increase of 102.
10%, the industry generally believes that the growth prospects of the manufacturing industry are promising, and its market demand will further increase in the future.

It is worth mentioning that, in this context, some insiders predict that the pharmaceutical equipment industry, as an important part of China’s manufacturing industry, will superimpose high-volume procurement, medical insurance investment, and medical care in the context of the booming manufacturing industry.
Expansion of consumer demand, the pharmaceutical industry is facing the impact of production capacity upgrades and other factors, and will usher in further development.

 

It is understood that under the general trend of rapid development of the pharmaceutical industry, pharmaceutical equipment has already belonged to the high-quality subdivision track in the machinery industry, and in the context of the expansion of the manufacturing PMI and the sharp increase in profits in the machinery industry, the industry has become even more so.
In a stage of rapid development.
The industry recommends to pay attention to related performance-guaranteed*, such as Chutian Technology, Tofflon, etc.

 

　　In fact, the pharmaceutical equipment industry, as an important part of my country's manufacturing industry, has ushered in further development under the influence of factors such as large-scale procurement, continuous advancement of medical insurance investment, rapid expansion of medical consumer demand, and accelerated production capacity upgrades in the pharmaceutical industry.
Recently, a number of listed pharmaceutical equipment companies have begun to disclose their performance reports for the first quarter of 2021, and their performance is expected to be positive.

 

　　For example, as a pharmaceutical equipment* with a complete product line and outstanding technology and service capabilities, Tofflon's performance in the first quarter of 2021 will show a rapid growth trend, achieving a net profit of 1.
08 to 123 million yuan attributable to the parent, and net profit attributable to the parent after deduction is 9,844.
16 -112.
5861 million yuan, maintaining the "buy" rating.

 

　　At present, numerous data fully show that my country's pharmaceutical equipment industry is showing a good development trend, especially the leading companies generally benefit from steady growth.
In the context of the recovery of the manufacturing industry, the industry predicts that in the next three quarters of 2020, my country's pharmaceutical equipment industry will achieve another success, and the performance of related companies may also be further improved.

 

　　However, since the technical level of pharmaceutical equipment determines the pharmaceutical level, industry insiders also said that for better development in the future, domestic pharmaceutical equipment companies also need to continuously increase investment in R&D and innovation, and continue to customize products according to the various needs of pharmaceutical companies.
Design, layout and service.
In fact, in terms of innovation, it has become the main theme of the development of the pharmaceutical industry, and the pharmaceutical equipment industry, which is closely related to it, has also begun to keep pace with the times and continue to innovate and upgrade in order to meet the needs of pharmaceutical companies.
It is reported that in order to promote the high-quality development of the pharmaceutical industry, domestic pharmaceutical equipment companies and the entire industry have begun to accelerate their exploration in the direction of intelligence and informatization.

 

　　For example, Chutian Technology has been deeply involved in intelligent manufacturing, and it has already begun to lay out both in terms of technology and concepts.
In recent years, through the acquisition of Sichuan Medical Design Institute, strategic cooperation with Siemens, the establishment of the Chutian Robot Intelligent Factory, the establishment of an intelligent medical equipment industrial park, and the establishment of joint ventures such as Chutian Huaxing, Chutian Yuanchuang, etc.
, multiple layouts have created "intelligence "Smart Pharmaceutical Factory" has entered the "Pharmaceutical Industry 4.
0 Era".

 

　　In general, the domestic pharmaceutical equipment industry has embarked on a road of rapid development.
With the development of the manufacturing industry in a good situation, it will usher in more opportunities in its development process.
However, it is worth noting that the development of an industry is always inseparable from R&D investment and talent investment.
Under the current background of rising labor costs and rising raw material prices in the pharmaceutical equipment industry, how to balance innovation and cost will become a matter for pharmaceutical equipment companies to speed up the solution.
A big challenge.

 

　　Original title: Manufacturing PMI increased month-on-month, and the pharmaceutical equipment industry will welcome good news